Join Now

Project Details
  • Title: Dendritic Cell Vaccine for Low-Grade Glioma Patients Trial
  • Date Proposed: 01/30/2012
  • Amount Requested: $100,000.00
  • Amount we Paid: $100,000.00
  • Paid Date: 06/01/2011
  • Stauts: Funded - and in progress!
  • Research name: Dr. Linda Liau
  • Hospital: University of California Los Angeles
  • Grey Ribbon Crusade Participants:
    • Accelerate Brain Cancer Cure
    • Miles For Hope
  • Simple Description: Accelerate Brain Cancer Cure partnered with Miles for Hope to play a key role in funding the new trial for low-grade glioma patients. Dr. Liau’s earlier study, launched in 2003, found that the personalized immunotherapy vaccine may double survival time for high-grade glioma (GBM) patients. The aim of the new phase 1 clinical trial is to test the safety and toxicity of the vaccine in low-grade patients.